Probes from several health regulators, including the U.S Food and Drug Administration (FDA), the U.K.s Medicines and Healthcare products Regulatory Agency (MHRA), and the European Medicines Agency, have all failed to find evidence that link GLP-1 drugs to suicide, suicidal thoughts, or actions
Twice-Weekly Semaglutide Dosing: What Research Shows Clinical trials establishing semaglutide's safety and efficacy used a once-weekly injection protocol, not twice-weekly dosing
Semaglutide has transformed weight management for millions by activating GLP-1 receptors in the brain, reducing appetite and increasing fullness signals
However, those who lose more weight initially maintain more significant weight loss compared to baseline than those who lose less before the medication is withdrawn
If you have experience with brand-name semaglutide and are transitioning to a compounded version, your storage habits may need to change